Seven isoquinoline alkaloids isolated from the bark of Actinodaphne macrophylla in this study demonstrated in vitro antiplasmodial activities against Plasmodium falciparum 3D7 with IC 50 values of 0.08 μM, 0.05 μM, 1.18 μM, 3.11 μM, 0.65 μM, 0.26 μM, and 1.38 μM for cycleanine, 10demethylxylopinine, reticuline, laurotetanine, bicuculine, -hydrastine and anolobine, respectively, which are comparable with the reference standard, chloroquine. 10-Demethylxylopinine was found to be the most active of these compounds.
Malaria is a disease caused by a parasite, transmitted by the bite of infected mosquitoes. Malaria produces recurrent attacks of fever and kills an estimated 1 million people each year worldwide [1a] . Plants of Actinodaphne are widely used traditionally for treating stomach-ache, rheumatism, inflammation and disorders of the urinary tract in many countries from South East Asia, India and China [1b]. In Malaysia, apart from treating general ailments, the leaves are also used as a mosquito repellent due to their fragrant smell [1c] .The main chemical constituents of these plants are isoquinoline alkaloids, which are clinically responsible for their pharmacological activities such as the well-known narcotic analgesics, morphine and codeine, apomorphine (a derivative of morphine) used in Parkinson's disease, the muscle relaxant papaverine, and the antimicrobial agents sanguinarine and berberine [1d]. Most interestingly, several plant extracts and isolated compounds from the Lauraceae family have been reported to have anti-malarial activity [1e]. In fact, several species in tropical regions have been identified to be potent against human malaria parasites [2a] . Malaysia is known for its vast tropical forest and green vegetation. Its diverse nature and multiple uses include medicinal values. The Malaysians also utilize traditional and herbal remedies as an alternative choice of treating malarial infection [2b].
The present study examined Actinodaphne macrophylla (Blume) from Lauraceae family to determine its anti-malarial activity by focusing on isoquinoline alkaloids: cycleanine (1), 10demethylxylopinine (2), reticuline (3), laurotetanine (4), bicuculine (5), α-hydrastine (6), parfumine (7) (which could not be obtained as a pure compound) and anolobine (8) (Figure 1 ). These isolated compounds were elucidated by spectroscopic methods [3] [4] [5] [6] [7] [8] [9] [10] and the seven pure alkaloids were used to study their in vitro activity against Plasmodium falciparum. Isoquinoline alkaloids from different plant families have been used widely for anti-malarial activity, such as protopine and coreximine form Corydalis crispa [11] . Results showed that the alkaloid crude extract has an IC 50 value of 0.5 ppm, which is considered active if less than 50 ppm [12a] . Table 1 shows the in vitro antiplasmodial activity against P. falciparum 3D7 of the isolated isoquinoline alkaloids. According to In comparison with chloroquine, 10demethylxylopinine (2), a protoberberine type alkaloid, was found to be the most active (IC 50 0.05 ± 0.04 μM), followed by cycleanine (1), α-hydrastine (6), bicuculine (5), reticuline (3), anolobine (8) and laurotetanine (4) . The potential of isoquinoline alkaloids as antimalarial agents has gained interest among natural product scientists for further study of these compounds [12c] . A previous report demonstrated that crude alkaloids of Brazilian plant species containing isoquinoline alkaloids had anti-malarial activity, but there was no further evaluation of the isolated alkaloids [13] . A recent study also reported the antimalarial activity of the crude alkaloid extract of A. macrophylla with an IC 50 of 0.1 ppm, but the compounds responsible for the bioactivity were not determined an acid and base extraction method. The crude extract (6.2 g) was fractionated on a silica gel column (CH 2 Cl 2 /MeOH, 100:0 → 50:50), followed by a Si-amine silica gel column (CH 2 Cl 2 /MeOH, 100:0→ 50:50) and finally purified by preparative HPLC (50-100% MeOH-H 2 O with detection at 248 and 283 nm, and a flow rate of 7 mL/min C18 Column) to yield cycleanine (1) (13 mg, 0.00048 %) ; 10demethylxylopinine (2) (8 mg, 0.00029 %); reticuline (3) (11 mg, 0.0004 %); laurotetanine (4) (10 mg, 0.000037 %); bicuculine (5) (8 mg, 0.00029 %), α-hydrastine (6) (10 mg, 0.000037 %); parfumine (7), (7 mg, 0.00025 %); and anolobine (8) (8 mg, 0.00029 %).
Antiplasmodial activity:
Continuous in vitro cultures of asexual erythrocytic stages of Plasmodium falciparum 3D7, a chloroquine sensitive strain, were maintained following the methods of Trager and Jensen [14] , on glucose-enriched RPMI 1640 medium, supplemented with 10% human serum at 37°C. The alkaloid crude extracts and pure compounds were tested against P. falciparum 3D7 [15] . The antimalarial activity of the isolated compounds and crude extracts was determined by the procedure described as follows. In brief, 1 mg of each sample was separately dissolved in DMSO and kept at -20 o C until used. The stock samples were further diluted ten-fold as required with RPMI 1640 medium. The final concentrations of samples were: 10, 1, 0.1, 0.01 and 0.001 µg/mL, respectively. The malarial parasite P. falciparum 3D7 was propagated in a 24-well culture plate with a wide range of concentrations for each sample. The growth of the parasite was monitored by performing blood smears. The percentage of growth inhibition was expressed according to the following equation: Growth inhibition % = 100 -(test parasitaemia/control parasitemia) × 100. Antimalarial activity of each sample was expressed as an IC 50 value, defined as the concentration of the sample causing 50% inhibition of parasite relative to an untreated control. Probit analysis with SPSS was used as statistical analysis to determine the IC 50 value [16] . Compounds or isolates that had an IC 50 value < 1-5 µM were considered active [12b]. 
